1800 202 8726
Breast biopsy results

LCIS on Your Biopsy Report: — What It Means and What Happens Next

A biopsy that comes back with LCIS often leaves people more confused than before, because the name sounds like cancer but the management is nothing like cancer treatment. LCIS is a risk marker found inside the breast lobules — it does not invade, does not spread, and in most cases does not need surgery. What it does need is a surveillance plan.

Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026

  • Not cancer — Despite the name, LCIS is a risk marker, not a cancer diagnosis. The word carcinoma was applied decades ago and is now considered misleading.
  • Surgery is rarely needed — LCIS is not routinely excised. Your treatment team will recommend surveillance rather than an operation in most cases.
  • Both breasts are watched — LCIS raises the risk of breast cancer in either breast, so follow-up covers both sides equally, not just where the biopsy was taken.
  • A plan, not a diagnosis — Finding LCIS means your oncologist will put a surveillance plan in place — closer monitoring so that any real change is caught early.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Talk to a medical oncologist

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

LCIS stands for Lobular Carcinoma In Situ. Despite the word carcinoma, it is not cancer — it is a marker that tells you your risk of developing breast cancer is higher than average. It does not need surgical removal in most cases. Your oncologist will recommend closer surveillance instead.

Is LCIS actually cancer?

LCIS is not cancer. The name is misleading — it was assigned decades ago, before pathologists understood that this finding behaves nothing like cancer.

The cells in LCIS stay inside the lobules, the milk-producing glands of the breast. They do not invade surrounding tissue, do not form a lump, and do not spread to other organs.

Modern guidelines from NCCN and ASCO classify LCIS as a risk marker, not a cancer diagnosis. Finding it means your risk of developing breast cancer in future is elevated — not that you have cancer now.

What follow-up do you need after LCIS?

  • Annual mammogram of both breasts
  • Annual breast MRI in many cases, particularly in women with dense breast tissue or a family history of breast cancer
  • A review of your overall breast cancer risk, including family history, at your next appointment
  • A conversation with your oncologist about whether risk-reducing medication is appropriate for you
  • Regular clinical breast examination at your follow-up visits
  • Report any new breast symptom — a lump, skin change or nipple discharge — to your team between appointments, without waiting for the next scheduled visit

Not sure what this means for you?

Share your reports and a senior oncologist will explain your options in plain language — no obligation to start treatment.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

You do not have to work this out alone

A 45-minute consultation with a specialist who treats this every week.

Book Free Consultation Call 1800 202 8726

Does LCIS need to be surgically removed?

In most cases, no. LCIS found on biopsy is not routinely excised the way DCIS is. Because the cells stay inside the lobule, there is no localised margin to clear in the same way.

There is one exception: a variant called pleomorphic LCIS has more abnormal-looking cells, and some guidelines recommend excision to examine the area more fully. Your pathology report will say whether your LCIS is classical or pleomorphic.

If your surgeon recommends surgery, ask why and what the specific finding in your report is. If surgery is not recommended, that is the expected outcome for classical LCIS — not a gap in your care.

Does LCIS in one breast affect the other breast?

Yes, and this surprises most people. LCIS raises the risk of developing invasive breast cancer in either breast — not only in the side where the biopsy was taken.

This is one of the key ways LCIS differs from a localised abnormality. Surveillance after LCIS covers both breasts equally, which is why imaging of both sides is part of the standard follow-up.

Family history of breast or ovarian cancer can raise that risk further. Tell your oncologist about any affected relatives, because it shapes both how closely you are monitored and whether a genetics referral is appropriate.

What should I ask my doctor about LCIS?

Does LCIS always turn into breast cancer?

No. Many people with LCIS never develop breast cancer. It is a risk marker — it tells your oncologist that your risk is elevated compared to the general population, not that cancer is certain or imminent. NCCN guidance treats LCIS as a reason for enhanced surveillance, not for treatment in itself. Regular monitoring is what allows any actual change to be found early.

What is the difference between LCIS and DCIS?

DCIS is found in the ducts and is treated as a localised pre-cancer that usually needs excision. LCIS is in the lobules and is treated as a general risk marker — it does not typically need removal, and there is no specific site that needs to be cleared. Your pathology report will state clearly which finding was seen and which management applies.

Should I consider risk-reducing medication?

This is worth raising with your oncologist. For women with LCIS, NCCN and ASCO guidelines recognise risk-reducing medication — such as tamoxifen or raloxifene, depending on your menopausal status — as an option that aims to lower the chance of developing invasive breast cancer. Whether it suits you depends on your age, medical history and personal circumstances.

What is pleomorphic LCIS, and is it more serious?

Pleomorphic LCIS has more abnormal-looking cells than the classical form. Some guidelines recommend excision to examine the area more fully when this variant is found, because its behaviour is less predictable. Your pathology report will say which variant you have. If it says pleomorphic, ask your surgeon specifically what management is recommended and why.

Will LCIS show up on future mammograms?

LCIS itself does not usually appear on a mammogram — it is typically found when a biopsy is done for another reason, such as a calcification. Future mammograms will look for new findings in both breasts. An annual MRI is often added to surveillance because it can detect changes that a mammogram might miss, particularly in women with dense breast tissue.

Do my daughters or sisters need to know?

Yes. LCIS in a first-degree relative — a mother, sister or daughter — is one of the factors that can raise a woman's breast cancer risk. Your relatives do not need to act immediately, but they should mention it to their own doctors so that their risk can be properly assessed. Ask your oncologist whether a genetics referral is appropriate for your family.

Explore 102 more Your Result, What Comes Next and Support topics

HUB — Who Can Have a Biopsy? Special Situations

HUB — Your Biopsy Confirmed Cancer

All Your Result, What Comes Next and Support →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

My biopsy says LCIS. Does that mean I have breast cancer?

No. LCIS is not a breast cancer diagnosis. The word carcinoma in the name is a historical label — modern guidance from NCCN and ASCO treats LCIS as a risk marker, not cancer. It means your risk of developing breast cancer in future is elevated compared to the general population, not that cancer is present now or will definitely develop. Many people with LCIS never develop breast cancer.

Will I need an operation after LCIS on biopsy?

In most cases, no. Classical LCIS found on biopsy is not routinely excised. Pleomorphic LCIS — a variant with more abnormal cells — may be managed differently, and some guidelines recommend excision in that case. If your surgeon recommends surgery, ask whether your report showed classical or pleomorphic LCIS and ask for the reasoning in plain terms. If surgery is not recommended, that is the expected outcome for classical LCIS.

How often do I need scans and appointments after LCIS?

Surveillance after LCIS typically involves annual mammography and, in many cases, annual breast MRI — particularly if you are younger or have dense breast tissue. Your oncologist will advise on the schedule that fits your specific risk profile. The exact plan is not the same for every person, so the specifics should come from your treating team rather than a general rule.

Can LCIS become cancer if I do nothing?

LCIS is a risk marker, not a condition that reliably progresses to cancer on a fixed timeline. Most people with LCIS do not go on to develop invasive breast cancer. The risk is real and ongoing, which is why surveillance continues over years. If a change does develop in either breast, catching it early through regular monitoring is what makes a difference to outcomes.

Are there lifestyle changes that help after LCIS?

Maintaining a healthy weight, limiting alcohol and staying physically active are associated with breast cancer risk in the general population, and your oncologist may raise these. None of them replace surveillance. Your oncologist may also discuss risk-reducing medication as an option, which NCCN and ASCO include in guidance for women with LCIS. Decisions about medication should be made with your treating team.

Should I have genetic testing after LCIS?

Not automatically, but it is worth discussing. LCIS itself is not a genetic condition, but it can co-exist with an elevated inherited risk. If you have a family history of breast or ovarian cancer in a first-degree relative, mention it to your oncologist — they may refer you for genetic counselling to assess whether BRCA or other gene testing is appropriate. Family history changes both your surveillance plan and the genetics question.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation